- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iradimed Co (IRMD)
Iradimed Co stock price live, this page displays NASDAQ IRMD stock exchange data. View the IRMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Iradimed Co real time stock price chart below.
What Is the Iradimed Co Stock Price Today?
The Iradimed Co stock price today is 90.86.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRMD quote. (ISIN: US46266A1097)
What Is the Iradimed Co Stock Price Today?
The Iradimed Co stock price today is 90.86.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the NASDAQ stock exchange.
Is Iradimed Co a Good Stock to Buy?
Determining whether Iradimed Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRMD quote. (ISIN: US46266A1097)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
89.51
97.74
52 wk Range
66.78
107.90
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
89.5197.74
52 wk Range
66.78107.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
118.00
Upside
+29.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Form 144 IRADIMED CORPORATION For: 4 June- Investing.com
Form 4 Iradimed Co For: 23 June- Investing.com
Iradimed director sells $285,000 in company stock- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 118.00
(+29.87% Upside)
Iradimed Co Earnings Call Summary for Q2/2026
- IRadimed Q2 2026 non-GAAP EPS of $0.46 and revenue of $20.47M both exceeded Wall Street estimates despite shares falling 1.72% to $93.58.
- Stock trades at P/E ratio of 50.83; InvestingPro analysis indicates shares are overvalued relative to fair value estimates.
- Margins compressed during major product transition to new 3870 model, tempering investor enthusiasm despite revenue beat.
- Revenue growth remained modest as company navigates product ramp-up phase, weighing on profitability metrics in the quarter.
Last Updated: 2026/07/31, 18:36
Read Full TranscriptEarnings
Latest Release
Jul 31, 2026
EPS / Forecast
0,46 / 0,45
Revenue / Forecast
20,5M / 20,56M
Compare IRMD to Peers and Sector
Metrics to compare | IRMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 50.4x | 15.4x | −0.4x | |
PEG Ratio | 4.51 | 0.07 | 0.00 | |
Price/Book | 11.4x | 5.4x | 2.6x | |
Price / LTM Sales | 13.5x | 3.1x | 3.0x | |
Upside (Analyst Target) | 29.9% | 43.3% | 56.0% | |
Fair Value Upside | Unlock | 5.5% | 9.1% | Unlock |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Iradimed Co (IRMD) Stock Price Today?
The Iradimed Co stock price today is 90,86 USD.
What Stock Exchange Does Iradimed Co Trade On?
Iradimed Co is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Iradimed Co?
The stock symbol for Iradimed Co is "IRMD."
Does Iradimed Co Pay Dividends? What’s The Current Dividend Yield?
The Iradimed Co dividend yield is 0.88%.
What Is the Iradimed Co Market Cap?
As of today, Iradimed Co market cap is 1,16B USD.
What Is Iradimed Co's Earnings Per Share (TTM)?
The Iradimed Co EPS (TTM) is 1,81.
When Is the Next Iradimed Co Earnings Date?
Iradimed Co will release its next earnings report on Oct 29, 2026.
From a Technical Analysis Perspective, Is IRMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Iradimed Co Stock Split?
Iradimed Co has split 0 times.
How Many Employees Does Iradimed Co Have?
Iradimed Co has 166 employees.
What is the current trading status of Iradimed Co (IRMD)?
As of Aug 03, 2026, Iradimed Co (IRMD) is trading at a price of 90,86 USD, with a previous close of 90,86 USD. The stock has fluctuated within a day range of 89,51 USD to 97,74 USD, while its 52-week range spans from 66,78 USD to 107,90 USD.
What Is Iradimed Co (IRMD) Price Target According to Analysts?
The average 12-month price target for Iradimed Co is 118,00 USD, with a high estimate of 120 USD and a low estimate of 116 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +29,87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.